Sources | Names Used |
---|---|
CTRPv2 | navitoclax:piperlongumine (1:1 mol/mol) |
PharmacoGx | navitoclax:piperlongumine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ARHGEF10L | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | THOC6 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | SOS1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | ARHGAP9 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
mRNA | ZNF564 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | FAM89B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | FEZ2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | MAP3K9 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | C3orf30 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | PCNT | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |